(Q46850181)

English

Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21122517

Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21122517

inflammatory bowel diseases

0 references

0 references

author name string

Peter Laszlo Lakatos

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21122517

Zsofia Czegledi

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21122517

Gyula David

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21122517

Zsofia Kispal

4

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21122517

Lajos S Kiss

5

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21122517

Karoly Palatka

6

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21122517

Tunde Kristof

7

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21122517

Ferenc Nagy

8

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21122517

Agnes Salamon

9

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21122517

Pal Demeter

10

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21122517

Pal Miheller

11

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21122517

Tamas Szamosi

12

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21122517

Janos Banai

13

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21122517

Maria Papp

14

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21122517

Laszlo Bene

15

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21122517

Agota Kovacs

16

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21122517

Istvan Racz

17

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21122517

Laszlo Lakatos

18

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21122517

publication date

1 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21122517

Journal of Crohn's and Colitis

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21122517

4

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21122517

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21122517

283-290

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21122517

Current concept on the pathogenesis of inflammatory bowel disease-crosstalk between genetic and microbial factors: pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take "toll" ?

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.011

21 January 2018

Recent trends in the epidemiology of inflammatory bowel diseases: up or down?

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.011

21 January 2018

Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.011

21 January 2018

Long-term aminosalicylate therapy is under-used in patients with ulcerative colitis: a cross-sectional survey

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.011

21 January 2018

Primary non-compliance with prescribed medication in primary care

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.011

21 January 2018

Review article: improving adherence to medication in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.011

21 January 2018

Predictors of medication adherence in inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.011

21 January 2018

Studies of compliance with delayed-release mesalazine therapy in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.011

21 January 2018

Review article: complementary and alternative therapies for inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.011

21 January 2018

Alternative medicine consultations and remedies in patients with the irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.011

21 January 2018

Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: results from a national survey

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.011

21 January 2018

Unconventional medicine in the United States. Prevalence, costs, and patterns of use

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.011

21 January 2018

Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.011

21 January 2018

Objective versus subjective assessment of oral medication adherence in pediatric inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.011

21 January 2018

Therapeutic drug monitoring of azathioprine and 6-mercaptopurine metabolites in Crohn disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.011

21 January 2018

Use of complementary and alternative medicine in Germany - a survey of patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.011

21 January 2018

Predictors of alternative and complementary medicine use in inflammatory bowel disease: do measures of conventional health care utilization relate to use?

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.11.011

21 January 2018

Identifiers

10.1016/J.CROHNS.2009.11.011

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21122517

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21122517

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46850181&oldid=2134702558"